by Clinical Neuropsychologist Online | Thursday, September 3, 2026 | Dementia
Dementia, Ahead of Print. Stigmatizing accounts of dementia emphasize tragedy, constructing people living with dementia as ‘unagentic’ and ‘failed’ aging subjects, and cognitive changes as a loss of self. This stigma has significant consequences for people living with...
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Tuesday, September 1, 2026 | Dementia
Abstract INTRODUCTION Plasma phosphorylated tau (p-tau), particularly p-tau217, is a highly specific biomarker of Alzheimer’s disease (AD) pathology. However, plasma p-tau217 can be elevated in rare non-AD conditions. Brain-derived (BD) p-tau217 may reduce these...
by Clinical Neuropsychologist Online | Monday, August 31, 2026 | Dementia
Abstract INTRODUCTION We tested whether quantitative transport mapping (QTM)-derived perfusion velocity would detect earlier and more sex-specific microvascular alterations than cerebral blood flow (CBF) across the Alzheimer’s disease (AD) continuum. METHODS In...
